FDA Inspection
Amryt Pharmaceuticals, Inc.Amryt Pharmaceuticals, Inc. – FDA Inspection, Jul 16, 2015
Record Details
This FDA Inspection record concerns Amryt Pharmaceuticals, Inc., with an inspection on July 16, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Amryt Pharmaceuticals, Inc.
- Inspection Date
- July 16, 2015
- Product Type
- Drugs
View Company Profile
ID · bbd0d1a7-4a50-4861-b85c-b447fe5011c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 947089
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 211.198(b)(1)Complaint Record required information
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amryt Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 27, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Amryt Pharmaceuticals, Inc.
- FDA Inspection 1180597 - 2022-09-14
- FDA Inspection 1122448 - 2020-01-23
- FDA Inspection 797858 - 2012-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.